calender_icon.png 20 February, 2026 | 5:16 AM

GHI Summit draws 2,800 participants

18-09-2025 12:00:00 AM

The RWEsearch & Health Innovation Summit 2025, hosted by Healthark, concluded after three days of high-level discussions that brought together more than 2,800 participants from 13 countries, 62 speakers, and 42 leading organizations. The summit focused on real-world evidence (RWE), artificial intelligence (AI), digital health, and innovation, shaping conversations on healthcare transformation across India, the Middle East, Africa, and beyond. The event was inaugurated by D. Sridhar Babu, Minister for Information Technology, Electronics, Communications, Industries and Legislative Affairs, Government of Telangana. He stressed the importance of platforms like this in guiding the future of RWE and AI in healthcare.

Ambassador Syed Akbaruddin, Founding Dean of the Kautilya School of Public Policy and former Permanent Representative of India to the UN, spoke at a private dinner with pharmaceutical leaders. He highlighted “The Current Geopolitical Complexity & Its Implications for Our Current Business,” sharing insights into risks and opportunities for healthcare and life sciences.

Adding an international perspective, Aditya Yellipeddi, former president of the Legislative Assembly, Chavornay, Switzerland, discussed the “Role of Indian GCCs in Global Healthcare Innovation,” emphasizing the value of Global Capability Centres in research and global collaboration.

A flagship panel on “Demystifying AI for the Next Generation of GCCs” brought leaders from Novo Nordisk, Bristol Myers Squibb, Roche Services & Solutions India, and Thermo Fisher Scientific. They highlighted AI’s role in clinical trials, R&D, and patient outcomes, with innovation moving from headcount-driven to impact-driven growth.

Chaired by Janak Joshi and Julie Krommenhoek, with Healthark founders Dr. Purav Gandhi and Sudeep Krishna, the summit featured 25 sessions covering AI-enabled research, regulatory frameworks, decentralized trials, and inclusivity in clinical research.